The use of cimetidine to reduce dapsone-dependent haematological side-effects in a patient with mucous membrane pemphigoid
- 1 December 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 34 (8), e1025-e1026
- https://doi.org/10.1111/j.1365-2230.2009.03710.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapyBritish Journal of Dermatology, 1995
- Dapsone: modes of action, toxicity and possible strategies for increasing patient toleranceBritish Journal of Dermatology, 1993
- The use of cimetidine to reduce dapsone‐dependent methaemoglobinaemia in dermatitis herpetiformis patients.British Journal of Clinical Pharmacology, 1992
- Dapsone Suppresses Integrin-Mediated Neutrophil Adherence FunctionJournal of Investigative Dermatology, 1992
- The use of cimetidine as a selective inhibitor of dapsone N‐ hydroxylation in man.British Journal of Clinical Pharmacology, 1990